Primary Category:
Radiation Oncology, Treatment Protocols
Disease Category:
Brain
Status:
Closed
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients with Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
NCT#04396860
BN007 is closed to accrual, effective March 29, 2023.
